{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:26:51Z","timestamp":1786782411166,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-026-10312-y","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:06:03Z","timestamp":1786781163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequence Variation of Epstein\u2013Barr Virus EBNA-1 Gene in Central Nervous System Inflammatory Demyelinating Diseases in Pakistan"],"prefix":"10.1007","volume":"21","author":[{"given":"Ayesha","family":"Munir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Nusrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"10312_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-422X-9-13","volume":"9","author":"J Ai","year":"2012","unstructured":"Ai J, Xie Z, Liu C, Huang Z, Xu J (2012) Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Virol J 9:13","journal-title":"Virol J"},{"key":"10312_CR2","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.radcr.2021.05.052","volume":"16","author":"N Almaghrabi","year":"2021","unstructured":"Almaghrabi N, Saab A (2021) Adult onset acute disseminated encephalomyelitis: A case report. Radiol Case Rep 16:2469\u20132473","journal-title":"Radiol Case Rep"},{"key":"10312_CR3","doi-asserted-by":"crossref","unstructured":"Almulla AF, Normatov MG, Supasitthumrong T, Maes M (2025) Molecular mimicry between Epstein-Barr virus and human herpesvirus-6 proteins and central nervous system proteins: Implications for T and B cell immunogenicity in an in silico study. bioRxiv 2025.04.02.646883.","DOI":"10.22541\/au.174538645.50552917\/v1"},{"key":"10312_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00430-018-0561-2","volume":"208","author":"AV Banko","year":"2019","unstructured":"Banko AV, Lazarevic IB, Karalic DZ, Djukic VB, Cupic MD, Stevanovic G, Jovanovic TP (2019) The sequence analysis of Epstein\u2013Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified? Med Microbiol Immunol 208:81\u201388","journal-title":"Med Microbiol Immunol"},{"key":"10312_CR6","first-page":"177","volume":"13","author":"K Bhatia","year":"1996","unstructured":"Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT (1996) Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas. Oncogene 13:177\u2013181","journal-title":"Oncogene"},{"key":"10312_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050084","volume":"7","author":"JN Chen","year":"2012","unstructured":"Chen JN, Zhang NN, Jiang Y, Hui DY, Wen ZJ, Li HG, Ding YG, Du H, Shao CK (2012) Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 7:e50084","journal-title":"PLoS One"},{"key":"10312_CR8","volume-title":"Autoantibodies","author":"U Christen","year":"2014","unstructured":"Christen U (2014) Molecular mimicry. Autoantibodies. Elsevier"},{"key":"10312_CR9","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N (2022) Epstein-Barr virus: Biology and clinical disease. Cell 185:3652\u20133670","journal-title":"Cell"},{"key":"10312_CR10","volume-title":"Biostatistics: A foundation for analysis in the health sciences","author":"WW Daniel","year":"2018","unstructured":"Daniel WW, Cross CL (2018) Biostatistics: A foundation for analysis in the health sciences. John Wiley & Sons"},{"key":"10312_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virusres.2007.10.020","volume":"132","author":"NV Do","year":"2008","unstructured":"Do NV, Ingemar E, Phi PT, Jenny A, Chinh TT, Zeng Y, Hu L (2008) A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res 132:15\u201324","journal-title":"Virus Res"},{"key":"10312_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/JVI.73.2.965-975.1999","volume":"73","author":"G Habeshaw","year":"1999","unstructured":"Habeshaw G, Yao QY, Bell AI, Morton D, Rickinson AB (1999) Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt\u2019s lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73:965\u2013975","journal-title":"J Virol"},{"key":"10312_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani A, Corboy JR, Al-Salam S, Khan G (2018) Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 13:e0192109","journal-title":"PLoS One"},{"key":"10312_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5603\/PJNNS.a2022.0046","volume":"56","author":"A Kalinowska-\u0141yszczarz","year":"2022","unstructured":"Kalinowska-\u0141yszczarz A, Guo Y, Lucchinetti CF (2022) Update on pathology of central nervous system inflammatory demyelinating diseases. Neurol Neurochir Pol 56:201\u2013209","journal-title":"Neurol Neurochir Pol"},{"key":"10312_CR15","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1212\/NXI.0000000000000406","volume":"4","author":"KL Kreft","year":"2017","unstructured":"Kreft KL, Van Nierop GP, Scherbeijn SM, Janssen M, Verjans GM, Hintzen RQ (2017) Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants. Neurol Neuroimmunol Neuroinflamm 4:e406","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10312_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezz A, Hintzen R, Kornberg A, Pohl D, Rostasy K (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261\u20131267","journal-title":"Mult Scler"},{"key":"10312_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, Teegen B, Dunn J, Lock CB, Kipp LB, Cotham VC, Ueberheide BM, Aftab BT, Anderson MS, DeRisi JL, Wilson MR, Bashford-Rogers RJM, Platten M, Garcia KC, Steinman L, Robinson WH (2022) Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603:321\u2013327","journal-title":"Nature"},{"key":"10312_CR18","doi-asserted-by":"crossref","unstructured":"Levinson JB, Alvarez MR, Koci K, Feoktistov A, McFarlane IM (2018) Epstein-Barr virus infection in a patient with neuromyelitis optica spectrum disorder and sj\u00f6gren\u2019s syndrome: A case report and review of literature. Clin Case Rep Rev 4","DOI":"10.15761\/CCRR.1000411"},{"key":"10312_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/archneurol.2011.34","volume":"68","author":"SM Maga\u00f1a","year":"2011","unstructured":"Maga\u00f1a SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J (2011) Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol 68:870\u2013878","journal-title":"Arch Neurol"},{"key":"10312_CR20","first-page":"1417","volume":"23","author":"SJ Mai","year":"2010","unstructured":"Mai SJ, Xie D, Huang YF, Wang FW, Liao YJ, Deng HX, Liu WJ, Hua WF, Zeng YX (2010) The enhanced transcriptional activity of the V-val subtype of Epstein-Barr virus nuclear antigen 1 in epithelial cell lines. Oncol Rep 23:1417\u20131424","journal-title":"Oncol Rep"},{"key":"10312_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/vaccines8010035","volume":"8","author":"PAC Maple","year":"2020","unstructured":"Maple PAC (2020) Cytomegalovirus and Epstein-Barr virus associations with neurological diseases and the need for vaccine development. Vaccines (Basel) 8:35","journal-title":"Vaccines (Basel)"},{"key":"10312_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jnnp-2014-308095","volume":"86","author":"S Masuda","year":"2015","unstructured":"Masuda S, Mori M, Arai K, Uzawa A, Muto M, Uchida T, Masuda H, Kuwabara S (2015) Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry 86:1137\u20131142","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10312_CR23","doi-asserted-by":"publisher","first-page":"e872","DOI":"10.1212\/NXI.0000000000000872","volume":"7","author":"JY Mescheriakova","year":"2020","unstructured":"Mescheriakova JY, Van Nierop GP, Van der Eijk AA, Kreft KL, Hintzen RQ (2020) EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution. Neurol Neuroimmunol Neuroinflamm 7:e872","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10312_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295124","volume":"18","author":"A Munir","year":"2023","unstructured":"Munir A, Khan S, Attaullah S, Munir M, Saleem A, Ali I (2023) Frequency and association of Epstein-Barr virus genotype in rheumatoid arthritis patients of Khyber Pakhtunkhwa, Pakistan. PLoS One 18:e0295124","journal-title":"PLoS One"},{"key":"10312_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/sji.70016","volume":"101","author":"A Munir","year":"2025","unstructured":"Munir A, Khan S, Saleem A, Nusrat H, Khan SA, Sayyed H, Khalid A, Javed B, Hidayat F (2025) The role of Epstein\u2013Barr virus molecular mimicry in various autoimmune diseases. Scand J Immunol 101:e70016","journal-title":"Scand J Immunol"},{"key":"10312_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12883-017-0858-6","volume":"17","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Nakajima H, Tani H, Hosokawa T, Ishida S, Kimura F, Kaneko K, Takahashi T, Nakashima I (2017) Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: A case report. BMC Neurol 17:76","journal-title":"BMC Neurol"},{"key":"10312_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2021.07.007","volume":"238","author":"N Sep\u00falveda","year":"2021","unstructured":"Sep\u00falveda N (2021) Impact of genetic variation on the molecular mimicry between Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in multiple sclerosis. Immunol Lett 238:29\u201331","journal-title":"Immunol Lett"},{"key":"10312_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1600-0404.2010.01410.x","volume":"124","author":"KC Simon","year":"2011","unstructured":"Simon KC, Yang X, Munger KL, Ascherio A (2011) EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurol Scand 124:53\u201358","journal-title":"Acta Neurol Scand"},{"key":"10312_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140529","volume":"10","author":"L Sun","year":"2015","unstructured":"Sun L, Zhao Z, Liu S, Liu X, Sun Z, Luo B (2015) Sequence variation analysis of Epstein-Barr virus nuclear antigen 1 gene in the virus associated lymphomas of northern China. PLoS One 10:e0140529","journal-title":"PLoS One"},{"key":"10312_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correaale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"10312_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2478\/bjmg-2019-0011","volume":"22","author":"LD Thuan","year":"2019","unstructured":"Thuan LD, Kha ND, Minh NT, Thuy L (2019) Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam. Balkan J Med Genet 22:61\u201368","journal-title":"Balkan J Med Genet"},{"key":"10312_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499\u2013505","journal-title":"Neurology"},{"key":"10312_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147567","volume":"11","author":"M Tschochner","year":"2016","unstructured":"Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, Kermode AG, Nolan D (2016) Identifying patient-specific Epstein-Barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PLoS One 11:e0147567","journal-title":"PLoS One"},{"key":"10312_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-023-05933-0","volume":"169","author":"Z Vafapour","year":"2024","unstructured":"Vafapour Z, Tabatabaie FH, Hosseini SY, Haghighat S, Hashemi SMA, Moattari A, Sarvari J (2024) Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic leukemia and healthy volunteer subjects. Arch Virol 169:1","journal-title":"Arch Virol"},{"key":"10312_CR35","doi-asserted-by":"crossref","unstructured":"Vietzen H, K\u00fchner LM, Berger SM, Furlano PL, Bsteh G, Berger T, Rommer P, Puchhammer-St\u00f6ckl E (2024) Accumulation of Epstein-Barr virus-induced cross-reactive immune responses is associated with multiple sclerosis. J Clin Invest 134","DOI":"10.1172\/JCI184481"},{"key":"10312_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, De Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Wassmer E, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"10312_CR37","doi-asserted-by":"publisher","first-page":"816098","DOI":"10.3389\/fmolb.2021.816098","volume":"8","author":"N Zhang","year":"2021","unstructured":"Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L (2021) Epstein-Barr virus and neurological diseases. Front Mol Biosci 8:816098","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-026-10312-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-026-10312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:06:05Z","timestamp":1786781165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-026-10312-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10312"],"URL":"https:\/\/doi.org\/10.1007\/s11481-026-10312-y","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Board of the University of Peshawar, Pakistan (Approval No. REB-03\/09; dated February 3, 2025). Written informed consent was obtained from all participants before enrollment and blood sample collection. Participants were informed of the study\u2019s purpose, assured of anonymity and confidentiality, and informed that participation was voluntary, with the right to withdraw at any time. All procedures were conducted in accordance with the ethical standards of the Declaration of Helsinki, and data protection protocols were strictly followed.","order":1,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"39"}}